Clinical Trial Update: The Use of DHEA in Women With Premature Ovarian Failure [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating dehydroepiandrosterone (DHEA) for premature ovarian failure was withdrawn with no reported results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ovarian Failure

Drugs mentioned

• DHEA (dehydroepiandrosterone)

Snippet

Sponsor: Virginia Center for Reproductive Medicine | Conditions: Premature Ovarian Failure | EARLY_Phase 1 | Status: WITHDRAWN